Help Fund Finding a Cure for Breast Cancer with 100K in 30 Days
Event Raises Three Million Euro To Date For Breast Cancer Research
Following the success of last year’s 100K in 30 Days event, which raised 1.7 million for Breast Cancer Ireland, organisers are calling on everyone, whether you’re based in Ireland or abroad, to join the #pinkarmy and take part in the June event. Registration is now open at
www.100kin30days.ie.
The event, sponsored by Sherry FitzGerald, is open to everyone – runners, walkers, those in wheelchairs, families, colleagues, schools, community groups, and sports teams. 100K in 30 Days was founded by Co. Louth (Blackrock, Dundalk) couple Niall Carroll and Cara McAdam and launched in 2020 after Cara was diagnosed with breast cancer. Over the last two years, 38,000 people in 36 countries have taken part raising €3million for Breast Cancer Ireland.
The funds has gone towards:
Clinical Trial Centre
Equipment for a new state-of-the-art Clinical Trial Centre due to open at the new Breast Centre on the Beaumont Hospital Campus in June. This new Centre will offer truly translational medicine to patients and will change the landscape positively into the future. All of this will take place under one roof under the watchful eye of a multidisciplinary team
The Shamrock Trial
The Shamrock Trial – a new clinical trial into Her2+ breast cancer that is being created to examine a fourth generation drug and its effectiveness as part of the treatment plan, de-escalating the need for chemotherapy in the process
Research Nurses
Research Nurses – supporting specialist breast research nurses in the eight designated cancer centres, whose role is to collaborate and collect patient tissue and serum samples into one large national biobank, allowing clinicians and scientists nationally to avail of the full yearly compliment (3,700) and thereby speeding up research discovery output. Before these nurses were recruited, each Centre may have had 1 paper in 18-24 months, and now in the past year one centre alone has 12 peer reviewed research papers published, activating new clinical trials.
Triple-Negative breast cancer research
Triple-Negative breast cancer research – led by Dr Paul Mullan, from the Patrick G Johnston Centre for Cancer Research at Queens University Belfast. This research, which commenced in October 2018, is now showing very promising results in the fight against the growth and spread of the most aggressive Triple Negative Breast Cancers (TNBC’s). Research is progressing and is close to publication / clinical trial development.
